Mallinckrodt - Nuclear Imaging Business' Merger

Mallinckrodt - Nuclear Imaging Business raised a round of funding on April 06, 2017. Investors include Curium.

Mallinckrodt, the pharmaceuticals business of Covidien, provides products used in diagnostic procedures and in the treatment of pain and related conditions.The company is a supplier of prescription op…

Articles about Mallinckrodt - Nuclear Imaging Business' Merger: